Axabin®

INDICATIONS

•  Axabin 2.5mg, co-administered with low dose Aspirin (75– 100 mg) alone or with ASA plus clopidogrel, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers
•  Axabin 2.5mg, co-administered with low dose Aspirin (75– 100 mg), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischemic events.
• Axabin® is the first generic form of rivaroxaban in Iran which is produced at a GMP approved manufacturing site